详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Kinase Domain Mutation Positive Lung Cancers Are Sensitive Intrapleural Perfusion with Hyperthermic Chemotherapy (IPHC) Complete Treatment

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

机构： [1]School of Life Science, Tsinghua University, Beijing 100084, China [2]National Institute of Biological Sciences, Beijing 102206, China [3]Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China [4]The General Hospital of People’s Liberation Army (301 Hospital), Beijing 100853, China [5]Peking Union Medical College Hospital, Beijing 100730, China [6]Collaborative Innovation Center of Systems Biomedicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China [7]National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, 102206, China

出处：

ISSN：

关键词： Kinase domain mutation intrapleural perfusion hyperthermic chemotherapy

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2014]版：

大类 | 2 区医学

小类 | 2 区肿瘤学 2 区呼吸系统

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

JCR分区：

出版当年[2013]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

最新[2023]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 21.1 最新[2023版] 16.5 最新五年平均 5.8 出版当年[2013版] 4.948 出版当年五年平均 4.473 出版前一年[2012版] 5.282 出版后一年[2014版]

第一作者：

第一作者机构： [1]School of Life Science, Tsinghua University, Beijing 100084, China [2]National Institute of Biological Sciences, Beijing 102206, China

通讯作者：

通讯机构： [2]National Institute of Biological Sciences, Beijing 102206, China [6]Collaborative Innovation Center of Systems Biomedicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China [7]National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, 102206, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment. [2]EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment [3]Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment. [4]Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination [5]Hyperthermic Intrapleural Chemotherapy By VATS For Lung Adenocarcinoma With Pleural Dissemination [6]THORACOSCOPIC TALC PLEURODESIS WITH HYPERTHERMIC INTRAPLEURAL CHEMOTHERAPY TO TREAT NSCLC WITH PLEURAL DISSEMINATION [7]Hyperthermic intrapleural chemotherapy combined with endostar by video-assisted thoracoscopic surgery for lung adenocarcinoma with pleural dissemination [8]HYPERTHERMIC INTRAPLEURAL CHEMOTHERAPY COMBINED WITH ENDOSTAR BY VIDEO-ASSISTED THORACOSCOPIC SURGERY FOR LUNG ADENOCARCINOMA WITH PLEURAL DISSEMINATION [9]Hyperthermic intrapleural chemotherapy combined with endostar by video-assisted thoracoscopic surgery for lung adenocarcinoma with pleural dissemination [10]Glaucomatous Injury of Central Nerve System